ERBB2 and breast cancer: Among these subtypes, triple-negative breast cancer (TNBC), lacking the expression of all three receptors (ER, PR, and HER2), accounts for 15–20% of all breast cancer cases and exhibits the most aggressive cancer phenotypes5.